These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
5. Impact of specific high-risk human papillomavirus genotypes on survival in oropharyngeal cancer. Garset-Zamani M; Carlander AF; Jakobsen KK; Friborg J; Kiss K; Marvig RL; Olsen C; Nielsen FC; Andersen E; Grønhøj C; von Buchwald C Int J Cancer; 2022 Apr; 150(7):1174-1183. PubMed ID: 34894151 [TBL] [Abstract][Full Text] [Related]
6. Prognostic significance of human papillomavirus 16 viral load level in patients with oropharyngeal cancer. Hashida Y; Higuchi T; Matsumoto S; Iguchi M; Murakami I; Hyodo M; Daibata M Cancer Sci; 2021 Oct; 112(10):4404-4417. PubMed ID: 34382311 [TBL] [Abstract][Full Text] [Related]
7. Detection of HPV16 African variants and quantitative analysis of viral DNA methylation in oropharyngeal squamous cell carcinomas. Barbieri D; Nebiaj A; Strammiello R; Agosti R; Sciascia S; Gallinella G; Landini MP; Caliceti U; Venturoli S J Clin Virol; 2014 Jul; 60(3):243-9. PubMed ID: 24845262 [TBL] [Abstract][Full Text] [Related]
8. Understanding the impact of high-risk human papillomavirus on oropharyngeal squamous cell carcinomas in Taiwan: A retrospective cohort study. Lorenzatti Hiles G; Chang KP; Bellile EL; Wang CI; Yen WC; Goudsmit CM; Briggs HL; Thomas TB; Peters L; Afsari MA; Pinatti LM; Morris AC; Jawad N; Carey TE; Walline HM PLoS One; 2021; 16(4):e0250530. PubMed ID: 33891627 [TBL] [Abstract][Full Text] [Related]
9. Human Papillomavirus 16 Infection and TP53 Mutation: Two Distinct Pathogeneses for Oropharyngeal Squamous Cell Carcinoma in an Eastern Chinese Population. Wang Z; Xia RH; Ye DX; Li J PLoS One; 2016; 11(10):e0164491. PubMed ID: 27749915 [TBL] [Abstract][Full Text] [Related]
10. Cancer stem cell enrichment marker CD98: a prognostic factor for survival in patients with human papillomavirus-positive oropharyngeal cancer. Rietbergen MM; Martens-de Kemp SR; Bloemena E; Witte BI; Brink A; Baatenburg de Jong RJ; Leemans CR; Braakhuis BJ; Brakenhoff RH Eur J Cancer; 2014 Mar; 50(4):765-73. PubMed ID: 24315751 [TBL] [Abstract][Full Text] [Related]
11. Prognostic factors for human papillomavirus-positive and negative oropharyngeal carcinomas. Yin LX; D'Souza G; Westra WH; Wang SJ; van Zante A; Zhang Y; Rettig EM; Ryan WR; Ha PK; Wentz A; Koch W; Eisele DW; Fakhry C Laryngoscope; 2018 Aug; 128(8):E287-E295. PubMed ID: 29536542 [TBL] [Abstract][Full Text] [Related]
12. Molecular subclassification determined by human papillomavirus and epidermal growth factor receptor status is associated with the prognosis of oropharyngeal squamous cell carcinoma. Nakano T; Yamamoto H; Nakashima T; Nishijima T; Satoh M; Hatanaka Y; Shiratsuchi H; Yasumatsu R; Toh S; Komune S; Oda Y Hum Pathol; 2016 Apr; 50():51-61. PubMed ID: 26997438 [TBL] [Abstract][Full Text] [Related]
13. HPV16 E6/E7 expression in circulating tumor cells in oropharyngeal squamous cell cancers: A pilot study. Economopoulou P; Koutsodontis G; Avgeris M; Strati A; Kroupis C; Pateras I; Kirodimos E; Giotakis E; Kotsantis I; Maragoudakis P; Gorgoulis V; Scorilas A; Lianidou E; Psyrri A PLoS One; 2019; 14(5):e0215984. PubMed ID: 31071126 [TBL] [Abstract][Full Text] [Related]
14. Predictors of overall survival in human papillomavirus-associated oropharyngeal cancer using the National Cancer Data Base. Amini A; Jasem J; Jones BL; Robin TP; McDermott JD; Bhatia S; Raben D; Jimeno A; Bowles DW; Karam SD Oral Oncol; 2016 May; 56():1-7. PubMed ID: 27086480 [TBL] [Abstract][Full Text] [Related]
15. Survival for HPV-positive oropharyngeal squamous cell carcinoma with surgical versus non-surgical treatment approach: A systematic review and meta-analysis. Sinha P; Karadaghy OA; Doering MM; Tuuli MG; Jackson RS; Haughey BH Oral Oncol; 2018 Nov; 86():121-131. PubMed ID: 30409292 [TBL] [Abstract][Full Text] [Related]
16. Tobacco exposure as a major modifier of oncologic outcomes in human papillomavirus (HPV) associated oropharyngeal squamous cell carcinoma. Elhalawani H; Mohamed ASR; Elgohari B; Lin TA; Sikora AG; Lai SY; Abusaif A; Phan J; Morrison WH; Gunn GB; Rosenthal DI; Garden AS; Fuller CD; Sandulache VC BMC Cancer; 2020 Sep; 20(1):912. PubMed ID: 32967643 [TBL] [Abstract][Full Text] [Related]
17. Clinical characteristics and outcomes of oropharyngeal carcinoma related to high-risk non-human papillomavirus16 viral subtypes. Varier I; Keeley BR; Krupar R; Patsias A; Dong J; Gupta N; Parasher AK; Genden EM; Miles BA; Teng M; Bakst RL; Gupta V; Misiukiewicz KJ; Chiao EY; Scheurer ME; Laban S; Zhang D; Ye F; Cui M; Demicco EG; Posner MR; Sikora AG Head Neck; 2016 Sep; 38(9):1330-7. PubMed ID: 27080140 [TBL] [Abstract][Full Text] [Related]
18. No evidence for active human papillomavirus (HPV) in fields surrounding HPV-positive oropharyngeal tumors. Rietbergen MM; Braakhuis BJ; Moukhtari N; Bloemena E; Brink A; Sie D; Ylstra B; Baatenburg de Jong RJ; Snijders PJ; Brakenhoff RH; Leemans CR J Oral Pathol Med; 2014 Feb; 43(2):137-42. PubMed ID: 24118314 [TBL] [Abstract][Full Text] [Related]
19. HPV16 increases the number of migratory cancer stem cells and modulates their miRNA expression profile in oropharyngeal cancer. Hufbauer M; Maltseva M; Meinrath J; Lechner A; Beutner D; Huebbers CU; Akgül B Int J Cancer; 2018 Sep; 143(6):1426-1439. PubMed ID: 29663357 [TBL] [Abstract][Full Text] [Related]
20. HPV Serum Antibodies as Predictors of Survival and Disease Progression in Patients with HPV-Positive Squamous Cell Carcinoma of the Oropharynx. Dahlstrom KR; Anderson KS; Cheng JN; Chowell D; Li G; Posner M; Sturgis EM Clin Cancer Res; 2015 Jun; 21(12):2861-9. PubMed ID: 26078432 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]